 On Thursday, August 06, Amphastar Pharmaceuticals NASDAQ: AMPH will release its latest earnings report. Benzingas report can help you figure out the ins and outs of the earnings release.Earnings and Revenue Analysts expect Amphastar Pharmaceuticals earnings of 0.14 per share. Revenue will likely be around 86.62 million, according to the consensus estimate. In the same quarter last year, Amphastar Pharmaceuticals reported EPS of 0.080 on revenue of 79.05 million. If the company were to match the consensus estimate, earnings would be up 75.0. Amphastar Pharmaceuticalss reported EPS has stacked up against analyst estimates in the past like this:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate 0.08 0.07 0.07 0.03 EPS Actual 0.17 0.07 0.10 0.08 Revenue Estimate 82.83 M 81.79 M 78.53 M 77.61 M Revenue Actual 84.69 M 83.38 M 80.14 M 79.05 M Stock Performance Over the last 52-week period, shares are down 1.19. Given that these returns are generally negative, long-term shareholders are probably down going into this earnings release.View more earnings on AMPHDont be surprised to see the stock move on comments made during its conference call. Amphastar Pharmaceuticals is scheduled to hold the call at 17:00:00 ET and can be accessed here: more from Benzinga Earnings Outlook For Appian Earnings Preview for American Vanguard Alteryx Earnings PreviewC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 